This morning, Ovid Therapeutics, a small biotechnology company, is announcing data indicating that a drug, gaboxadol, may be of some help for patients with a condition called Angelman Syndrome.
Ovid Therapeutics Drug, Invented 41 Years Ago, May Help People With A Rare Disorder
